Myotonia Congenita

Myotonia congenita is a disorder that causes sustained tensing of skeletal muscles, preventing them from relaxing. This feed focuses on mechanisms that underlie this condition and therapeutic strategies used for its treatment.

August 30, 2020
Open Access

Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies

ESC Heart Failure
Guilherme Wesley Peixoto da FonsecaStephan von Haehling
September 1, 2020

Degradation of Toxic RNA in Myotonic Dystrophy Using Gapmer Antisense Oligonucleotides

Methods in Molecular Biology
Quynh Nguyen, Toshifumi Yokota
August 28, 2020
Preprint
Open Access

Genetic Variation Analysis and Treatment Strategy of 20 Patients with Dystrophin Gene Mutations

ResearchSquare
Yedan LiuZongbo Chen
August 29, 2020
Open Access

Long-term Effects of Calcium β-Hydroxy-β-methylbutyrate (HMB) and Vitamin D3 Supplementation on Muscular Function in Older Adults with and without Resistance Training: A Randomized, Double-blind, Controlled Study

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
John A RathmacherRick L Sharp
August 28, 2020

Changes in skeletal muscle diffusion parameters owing to intramyocellular lipid

Magnetic Resonance Imaging
Kiichi TadanoTakeji Sakae
August 31, 2020

Frailty measures can be used to predict the outcome of kidney transplant evaluation

Surgery
Priyadarshini ManayDaniel A Katz
September 10, 2020
Open Access

Iron deficiency, fatigue and muscle strength and function in older hospitalized patients

European Journal of Clinical Nutrition
Sophia NeidleinMaryam Pourhassan
August 28, 2020

Acute Myocardial Infarction in a Young Bodybuilder: A Case Report and Review of the Literature

The American Journal of Case Reports
Abrão José MelhemDavid Livingstone A Figueiredo
August 31, 2020

Pathogenic deep intronic MTM1 variant activates a pseudo-exon encoding a nonsense codon resulting in severe X-linked myotubular myopathy

European Journal of Human Genetics : EJHG
Samantha J BryenSandra T Cooper
September 6, 2020

How to capture activities of daily living in myotonic dystrophy type 2?

Neuromuscular Disorders : NMD
Federica MontagneseBenedikt Schoser
September 8, 2020
Open Access

Myocardial T1 -mapping and Extracellular Volume Quantification in Patients and Putative Carriers of Muscular Dystrophy: Early Experience

Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine
Kazuhiro KoyanagawaToshihisa Anzai
September 18, 2020

Cardiovascular Responses to Rhythmic Handgrip Exercise in Heart Failure with Preserved Ejection Fraction

Journal of Applied Physiology
Stephen M RatchfordD Walter Wray
September 15, 2020

Quality of Life and Functional Mobility After Progressive Resistance Exercise in an Adolescent With a Liver Transplant

Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association
Julie A Burkhardt, Mary Jane K Rapport
August 30, 2020
Open Access

Pathological evaluation of rats carrying in-frame mutations in the dystrophin gene: A new model of Becker muscular dystrophy

Disease Models & Mechanisms
Naomi TeramotoMasugi Nishihara
September 25, 2020
Open Access

Comparison of Agar Dilution to Broth Microdilution for Testing in vitro Activity of Cefiderocol against Gram-negative Bacilli

Journal of Clinical Microbiology
Mariana AlbanoRobin Patel
September 5, 2020

Endothelial function and shear stress in hypobaric hypoxia: time course and impact of plasma volume expansion in men

American Journal of Physiology. Heart and Circulatory Physiology
Joshua C TremblayChristoph Siebenmann

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/myotonia-congenita/7536e1c3-b119-4b94-87d1-4603b43f6f4e